MiR-155-mediated loss of C/EBPI2 shifts the TGF-I2 response from...

EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer Correspondence: Professor J Fuxe, Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Scheeles v.

http://www.nature.com/onc/journal/vaop/ncurrent/full/onc2013322a.html